FINWIRES · TerminalLIVE
FINWIRES

Concentra Poised to Benefit From AI Data Center Development, RBC Says

By

Concentra Group (CON) is positioned to benefit from a potential pickup in manufacturing and construction activity, particularly in markets benefiting from AI data center development, as management expressed cautious optimism about early signs of a pickup, RBC Capital Markets said in a Monday note.

The company delivered strong Q2 results and raised its 2026 guidance, while management pointed to a potential increase in manufacturing and construction activity, particularly in markets involved in AI data center development.

The company is "cautiously optimistic" on early indicators of a rise in construction activity, particularly in Texas and Oklahoma where there is significant data center development, RBC said.

Workers' compensation visits are tracking at some of the highest levels in two decades, and the company noted that large projects typically bring in further infrastructure and employment within the next couple of years, leading to an opportunity for volumes.

Concentra has established business relationships with large construction companies involved in the projects, and it believes it is poised to capture incremental volume as the projects progress, according to the note.

Further, Concentra has attained its delevering target earlier than expected, which sets it up for continued acquisitions and expansion.

RBC reiterated its outperform rating on the company's stock and raised its price target to $42 from $36.

Price: $33.63, Change: $-0.43, Percent Change: -1.26%

Related Articles

Wire

GRAIL's Galleri Blood Test to Be Evaluated by US FDA Advisory Panel

GRAIL (GRAL) said Friday that an advisory panel of the US Food and Drug Administration will convene on Sept. 23 to evaluate the premarket approval application for its Galleri multi-cancer early detection blood test.The firm submitted the marketing application Jan. 29, incorporating trial results from 25,490 participants in its PATHFINDER 2 study along with over 70,000 subjects from its NHS-Galleri trial, the company said.Shares of the company were up about 8.9% in Friday trading.Price: $69.03, Change: $+5.63, Percent Change: +8.88%

$GRAL
Wire

Top Cryptocurrencies Rise; Bitcoin Holds Above $64,000

Major digital assets rose Friday with Bitcoin (BTC-USD) still holding above $64,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 0.3% in the past 24 hours. The Nasdaq 100 added 1.3%, the S&P 500 gained 0.6%, and the Dow Jones Industrial Average increased 0.2%.Bitcoin gained 0.9% to $64,938, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose almost 11% to $21.65 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 0.6% to $1,918.XRP (XRP-USD) fell 1.1%, BNB (BNB-USD) increased 0.5%, and Solana (SOL-USD) rose 1.5%. Dogecoin (DOGE-USD) added 1.6%, while Cardano (ADA-USD) dropped 0.8%.The total market value of the cryptocurrency industry rose 0.6% in the past 24 hours to $2.21 trillion, with trading volume rising 5.3% to $55.6 billion.Price: $64913.74, Change: $+654.06, Percent Change: +1.02%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Celestica Completes $3.45 Billion Equity Offering

Celestica (CLS) said Friday it completed a $3.45 billion equity offering through the sale of about 11.1 million common shares priced at $310 each.The offering comprised roughly 9.7 million common shares, with the underwriters fully exercising their option to purchase an additional 1.5 million shares.Celestica said it expects to use the net proceeds for working capital, investments in capital expenditures and other general corporate purposes.Price: $317.60, Change: $+3.07, Percent Change: +0.98%

$CLS